Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1 1

Status

Completed 63Recruiting 24Unknown 22Terminated 6Not yet recruiting 5Active not recruiting 5Withdrawn 3Enrolling by invitation 1

Sponsor Class

OTHER 2NETWORK 2INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 6Neoplasm Metastasis 4Colonic Neoplasms 4Rectal Neoplasms 3Stomach Neoplasms 2Peritoneal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Disease Progression 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Bile Duct Neoplasms 1

Interventions

Irinotecan 58Bevacizumab 56Oxaliplatin 49Leucovorin 49Fluorouracil 49Capecitabine 45Cetuximab 44pembrolizumab 23IFL protocol 15Nivolumab 11regorafenib 10Panitumumab 10Celecoxib 8Radiotherapy 7Cyclophosphamide 7atezolizumab 6Surgical Procedures, Operative 6Gemcitabine 6Folfox protocol 6Colonoscopy 6trifluridine tipiracil drug combination 5Neoadjuvant Therapy 5Metformin 5Immunohistochemistry 5Biopsy 5tislelizumab 4spartalizumab 4durvalumab 4Trastuzumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Colorectal Neoplasms × Folfox protocol × Clear all
NCT03117972 2025-02-05

CLavSyn

Centre Hospitalier Universitaire de Besancon

Phase 2 Terminated
54 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01167725 2024-12-27

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
340 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT05039944 2024-07-18

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2 Terminated
7 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03035253 2020-08-11

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

Mereo BioPharma

Phase 1 Terminated
16 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01508000 2016-10-12

BOS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
44 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00043004 2012-09-24

Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
119 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡